Back to results
US 6,034,233 AGranted
2'-O-alkylated oligoribonucleotides and phosphorothioate analogs complementary to portions of the HIV genome
AssigneeIsis Pharmaceuticals, Inc.
InventorsDavid Ecker, Timothy A. Vickers
Life of this patent
Estimating the term…
Abstract
Methods of modulating the activity of the TAR element of HIV are provided. Oligonucleotides having 6 to 50 bases and at least one 2'-O alkyl modification and selected sequences are disclosed.
Claims7
An oligonucleotide having a nucleotide sequence selected from the group consisting of SEQ. ID. No. 1, SEQ. ID. No. 2, SEQ. ID. No. 3, SEQ. ID. No. 5, SEQ. ID. No. 6, SEQ. ID. No. 7, SEQ. ID. No. 8, and SEQ. ID. No. 9 and at least one C.sub.1 to C.sub.9 alkyl or benzyl 2'-O-modification.
Dependencies are inferred from the claim text.